American Society of Echocardiography (ASE)

The American Society of Echocardiography (ASE) is the key cardiovascular ultrasound medical society. ASE works to advance cardiac ultrasound, offers clinical education, research, government policy advocacy, and services to the professionals and the public.

RSS icon

ASE establishes vocabulary for cardiac POCUS to promote consistency

As cardiac point-of-care ultrasound use continues to grow outside of traditional echo labs, the American Society of Echocardiography is working to ensure everyone is on the same page.

The American Society of Echocardiography (ASE) has shared new recommendations for performing medical imaging exams on heart failure patients with surgically implanted left ventricular assist devices (LVADs) and temporary mechanical circulatory support (TMCS) devices. The guideline, published in full in the Journal of the American Society of Echocardiography, represents ASE’s first update on the topic since 2015.[1]

ASE shares new guideline on imaging patients with implanted devices

The new guideline details the best imaging strategies for a variety of clinical scenarios. 

ASE President Ted Abraham, MD, speaking at the ASE HCM forum in 2023. Photo by Dave Fornell

Cardiologist begins term as American Society of Echocardiography's new president

Cardiologist Theodore Abraham, MD, has been an ASE member for more than two decades. He is now the organization's 2024-2025 president. 

More than 5,600 cardiac ultrasound measurements are now automated using artificial intelligence in the new Siemens Acuson Origin echocardiography system. It is the first echo system to use AI to help automate and anticipate next actions to greatly speed workfor and increase reproducibility between sonographers. Photo by Dave Fornell at ESC 2023

Cardiovascular ultrasound innovations being showcased at ASE 2024 meeting

New cardiac ultrasound advances, from AI to completely study workflow, new 3D/4D catheters, virtual reality simulators, to robot-assisted ultrasound, will be presented on the expo floor of ASE 2024 this weekend in Portland.

The central illustration from a study that shows the impact of ECG AI algorithm study case and control selection to train artificial intelligence to better screening patients for cardiac amyloidosis. Image courtesy of JACC Advances.

Using ECG AI to find the cardiac amyloidosis needles in the haystack

Early detection of cardiac amyloidosis is leads to the best outcomes, but it is often missed until later stages. AI is being developed to help detect these patients earlier using ECG and echo.

Luc Mertens, MD, section head of echocardiography at The Hospital for Sick Children in Toronto, explains application of ultrafast ultrasound and blood speckle imaging in echocardiography

Vector flow and blood speckle echocardiography imaging may unveil new clinical insights

Luc Mertens, MD, Hospital for Sick Children, Toronto, explains research and potential uses for ultrafast echo imaging.

Video interview with Marielle Scherrer-Crosbie, MD, Hospital of the University of Pennsylvania, who explains details of creating a cardio-oncology program, whoi should be involved and the role of cardiac imaging.

Key things to remember when creating a cardio-oncology program

Marielle Scherrer-Crosbie, MD, explains what is needed to create a cardio-oncology program, and the role played by cardiac imagers.

Marielle Scherrer-Crosbie, MD, Hospital of the University of Pennsylvania, discusses the latest trends in cardiac strain echo.

Interest in strain echo imaging is rising, but hurdles remain

Marielle Scherrer-Crosbie, MD, told Cardiovascular Business that the current lack of reimbursement for strain echocardiography has been a challenge for care teams. 

Displaying 1 - 8 of 88

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.